CURRENT ISSUE Current Issue Cover
VOL 10 NO 8 • NOV/DEC 2019
IN THIS ISSUE

Patient Safety and Disclosure

Pamela Hallquist Viale, RN, MS, CNS, ANP

The Development of an Oncology Clinical Nurse Specialist Fellowship Program

Allison Ann de Villiers,(1) MSN, APRN-CNS, OCN®, ACNS-BC, Lisa Maree Blackburn,(1) MS, APRN-CNS, RN-BC, AOCNS®, Danette Birkhimer,(1) MS, APRN-CNS, AOCNS®, Lynne R. Brophy,(1) MSN, APRN-CNS, RN-BC, AOCN®, Jamie Tippett,(1) MS, RN, NEA-BC, Karen Meade,(1) MS, APRN-CNS, AGCNS-BC, CPAN®, OCN®, and Carlton G. Brown,(2) PhD, RN, AOCN®, NEA-BC, FAAN


AL Amyloidosis: Unfolding a Complex Disease

Rebecca Lu, MS, FNP, and Tiffany A. Richards, PhD, ANP-BC

 
Section Seperator

TODAY'S NEWS

T-DXd in Patients With Pretreated HER2-P...

A phase II clinical study investigating [fam-] tra...

Adding Tucatinib to Capecitabine/Trastuz...

The addition of tucatinib to capecitabine and tras...

Ribociclib/Letrozole vs Multiagent Chemo...

A phase II study by Gavilá et al evaluating the ef...

Long-Term Preventive Benefit With Anastr...

A 10-year median follow-up analysis of the IBIS-II...

Breast Cancer Incidence With Estrogen/Pr...

A study investigating the long-term influence of e...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Cytokine Release Syndrome

CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights More Highlights
Section Seperator

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets More Tweets
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.